New Filings & Updated Terms: Pipeline suggests robust activity thru Thanksgiving

A total of 13 companies filed for IPO over the past seven days and five have set terms to debut next week.

NEW FILINGS

Company: Leslie’s, Inc.
Symbol: LESL
Description: They are the largest and most trusted direct-to-consumer brand in the nearly $11 billion United States pool and spa care industry, serving residential, professional, and commercial consumers.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, Morgan Stanley, BofA Securities
Filed: 10-7-20
Listed Cash Raise: $100m

Company: Galecto, Inc.
Symbol: GLTO
Description: They are a clinical-stage biotechnology company developing therapeutics that are designed to target the biological processes that lie at the heart of fibrosis and impact a broad range of fibrotic and related diseases, including cancer.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): BofA Securities, SVB Leerink, Credit Suisse
Filed: 10-7-20
Listed Cash Raise: $100m

Company: Lufax Holding Ltd
Symbol: LU
Description: They are a leading technology-empowered personal financial services platform in China.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, BofA Securities, UBS Investment Bank, HSBC, China PA Securities (Hong Kong) Company Limited, Morgan Stanley, CLSA. Jefferies
Filed: 10-7-20
Listed Cash Raise: $100m

Company: Mavenir plc
Symbol: MVNR
Description: They provide software to drive the digital transformation of mobile networks. Our suite of cloud-native software applications delivers the critical network functionality that allows Wireless Service Providers to meet the needs of their enterprise and consumer customers.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, Goldman Sachs, J.P. Morgan, BofA Securities, Barclays, Guggenheim Securities, Macquarie Capital
Filed: 10-7-20
Listed Cash Raise: $100m

Company: Allegro MicroSystems, Inc.
Symbol: ALGM
Description: Allegro MicroSystems is a leading global designer, developer, fabless manufacturer and marketer of sensor ICs and application-specific analog power ICs enabling the most important emerging technologies in the automotive and industrial markets.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Barclays, Credit Suisse, Wells Fargo
Co-Manager(s): Jefferies, Mizuho Securities, Needham, SMBC Nikko
Filed: 10-6-20
Listed Cash Raise: $100m

Company: Telos Corporation.
Symbol: TLS
Description: Telos Corporation offers technologically advanced, software-based security solutions that empower and protect the world’s most security-conscious organizations against rapidly evolving, sophisticated and pervasive threats..
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): B. Riley Securities, BMO Capital Markets, Needham & Company
Filed: 10-6-20
Listed Cash Raise: $241.5m

Company: MediaAlpha, Inc.
Symbol: MAX
Description: Their mission is to help insurance carriers and distributors target and acquire customers more efficiently and at greater scale through technology and data science.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): J.P. Morgan, Citigroup, Credit Suisse, RBC Capital Markets, Canaccord Genuity, William Blair
Co-Manager(s): MUFG
Filed: 10-5-20
Listed Cash Raise: $100m

Company: Root, Inc.
Symbol: ROOT
Description: Root is a technology company revolutionizing personal insurance with a pricing model based upon fairness and a modern customer experience.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, Morgan Stanley, Barclays, Wells Fargo Securities, Credit Suisse, Deutsche Bank Securities ,Evercore ISI, Truist Securities
Co-Manager(s): Cantor, JMP Securities, Siebert Williams Shank
Filed: 10-5-20
Listed Cash Raise: $100m

Company: Aspire Real Estate Investors, Inc.
Symbol: TBD
Description: They will be externally managed and advised by our Manager, which is majority owned and controlled by an affiliate of Avanath, a real estate investment manager that invests in property markets nationwide on behalf of pension funds and other institutional investors through commingled funds.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, B. Riley Securities, Wells Fargo Securities, BMO Capital Markets, KeyBanc Capital Markets
Filed: 10-2-20
Listed Cash Raise: $100m

Company: Abcam plc
Symbol: ABCM
Description: They are a global life science company focused on identifying, developing and distributing high-quality reagents and tools for our customers at the forefront of life science research. Their ordinary shares trade on AIM, a market of the London Stock Exchange, under the symbol “ABC.”
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, BofA Securities, SVB Leerink
Co-Manager(s): Lazard, William Blair
Filed: 10-2-20
Listed Cash Raise: $100m

Company: Foghorn Therapeutics Inc.
Symbol: FHTX
Description: They are pioneering the discovery and development of a new class of medicines targeting genetically determined dependencies within the chromatin regulatory system, an untapped opportunity for therapeutic intervention.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Goldman Sachs, Morgan Stanley, Cowen
Co-Manager: Wedbush PacGrow
Filed: 10-2-20
Listed Cash Raise: $100m

Company: Caliber Home Loans, Inc.
Symbol: HOMS
Description: They are a proven leader in the U.S. mortgage market with a uniquely diversified, customer-centric, purchase-focused platform.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Credit Suisse, Goldman Sachs, Barclays
Filed: 10-2-20
Listed Cash Raise: $100m

Company: Biodesix, Inc.
Symbol: BDSX
Description: They are a leading data-driven diagnostic solutions company leveraging state of the art technologies with our proprietary artificial intelligence (AI) platform to discover, develop, and commercialize solutions for clinical unmet needs, with a primary focus in lung disease.
Shares: TBD
Price Range: TBD
Trade Date: TBD
Underwriter(s): Morgan Stanley, William Blair
Co-Manager(s): Canaccord Genuity, BTIG
Filed: 10-2-20
Listed Cash Raise: $75m

UPDATED TERMS

Company: Codiak BioSciences, Inc.
Symbol: CDAK
Description: They are a development-stage biopharmaceutical company focused on pioneering the development of exosome-based therapeutics, a new class of medicines with the potential to transform the treatment of a wide spectrum of diseases with high unmet medical need.
Shares: 5.5 million
Price Range: $14.00-$16.00
Market Cap: $260m-$298m
Trade Date: Wednesday, 10/14
Underwriter(s): Goldman Sachs, Evercore ISI, William Blair
Co-Manager: Wedbush PacGrow
Terms Added: 10-7-20
Note: First Filed in April 2019

Company: Array Technologies, Inc.
Symbol: ARRY
Description: They are one of the world’s largest manufacturers of ground-mounting systems used in solar energy projects.
Shares: 33.75 million
Price Range: $19.00-$21.00
Market Cap: $2.4b-$2.7b
Trade Date: Thursday, 10/15
Underwriter(s): Goldman Sachs, J.P. Morgan, Guggenheim Securities, Morgan Stanley, Credit Suisse, Barclays, UBS Investment Bank
Co-Manager(s): Cowen, Oppenheimer, MUFG, Nomura
Terms Added: 10-7-20

Company: MINISO Group Holding Limited
Symbol: MNSO
Description: They are a fast-growing global value retailer offering a variety of design-led lifestyle products.
Shares: 30.4 million
Price Range: $16.50-$18.50
Market Cap: $5.0b-$5.6b
Trade Date: Week of 10/12
Underwriter(s): Goldman Sachs, BofA Securities
Terms Added: 10-7-20
Listed Cash Raise: $100m

Company: Spinal Elements Holdings, Inc.
Symbol: SPEL
Description: They are a medical device company focused on the design, development and commercialization of a comprehensive portfolio of systems, products and technologies for spine surgery procedures, with a strategic focus on minimally invasive surgery (“MIS”) procedures.
Shares: 7.7 million
Price Range: $13.00-$15.00
Market Cap: $353m-$407m
Trade Date: Thursday, 10/15
Underwriter(s): Credit Suisse, Baird, Stifel
Co-Manager(s): Truist Securities, BTIG, Siebert Williams Shank
Terms Added: 10-8-20

Company: Praxis Precision Medicines, Inc.
Symbol: PRAX
Description: They are a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system, or CNS, disorders characterized by neuronal imbalance.
Shares: 7.4 million
Price Range: $16.00-$18.00
Market Cap: $546m-$615m
Trade Date: Friday, 10/16
Underwriter(s): Cowen, Evercore ISI, Piper Sandler
Co-Manager(s): Wedbush PacGrow, Blackstone Capital
Terms Added: 10-9-20